Treatment & Supportive Care
Mesothelioma Treatments Beyond Chemotherapy
Immunotherapy, targeted agents, tumour treating fields, and trial options for mesothelioma beyond standard chemotherapy, and who is likely to benefit.
mesothelioma
Diagnosis, Pathology & Imaging
Monitoring Disease Progress in Mesothelioma
How mesothelioma progression is tracked through imaging, response criteria, and clinical assessment, and what changes on a scan actually mean.
Research & Emerging Therapies
Gene Therapy for Mesothelioma: What the Early Research Tried
Gene therapy for mesothelioma: what the early research tried, with cautious context about older research and what it may mean today
Research & Emerging Therapies
Mesothelioma Survivors and New Research
Mesothelioma Survivors: Pioneering Research and Promising Developments in the Fight Against Asbestos-Related Cancer
Research & Emerging Therapies
HGF, c-Met, and Other Molecular Signals in Mesothelioma
HGF, c-Met, and Other Molecular Signals in Mesothelioma guide to older evidence and its limits in plain English.
Diagnosis, Pathology & Imaging
Mesothelioma in Situ: The Earliest Stage of Mesothelioma
Mesothelioma in situ is the earliest recognised stage. How it is diagnosed, why it was only recently defined, and what it means for early treatment.
Legal & Compensation
Mesothelioma in South Africa: Future Outlook
Mesothelioma in South Africa after the asbestos mining era: incidence trends, compensation schemes, and the obstacles facing affected communities.
Diagnosis, Pathology & Imaging
Ancillary Studies in Mesothelioma Diagnosis: Distinguishing the Benign from the Malignant
Understanding ancillary studies in mesothelioma diagnosis and the role of immunohistochemistry, ploidy, and cytogenetics.
Diagnosis, Pathology & Imaging
Diagnosing Mesothelioma: Effusion Fluid, Biopsy, and Sampling Techniques
How pleural fluid analysis, needle biopsy, and thoracoscopic sampling diagnose mesothelioma, and why tissue usually beats fluid cytology for certainty.
Page 4 of 13